Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients

NCT: NCT03289364 · COMPLETED

NCT IDNCT03289364
StatusCOMPLETED
Start Date2017-08-24
Completion2021-08-19

Brief Summary

The goal of this study is to estimate the efficacy of Penguin cold caps in preventing or reducing hair loss in patients receiving (neo)adjuvant chemotherapy (one of four common regimens) for early stage breast cancer.

Frequently Asked Questions

What is Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients?

Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients is a clinical trial registered under NCT03289364. Current status: COMPLETED.

What is the status of NCT03289364?

The current status of NCT03289364 (Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients) is: COMPLETED.

When did Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients start?

Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients started on 2017-08-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑